46 related articles for article (PubMed ID: 15585598)
1. Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus.
Schultes B; Jauch-Chara K; Gais S; Hallschmid M; Reiprich E; Kern W; Oltmanns KM; Peters A; Fehm HL; Born J
PLoS Med; 2007 Feb; 4(2):e69. PubMed ID: 17326710
[TBL] [Abstract][Full Text] [Related]
2. Effects of γ-Aminobutyric Acid A Receptor Activation on Counterregulatory Responses to Subsequent Exercise in Individuals With Type 1 Diabetes.
Hedrington MS; Mikeladze M; Tate DB; Younk LM; Davis I; Davis SN
Diabetes; 2016 Sep; 65(9):2754-9. PubMed ID: 27217489
[TBL] [Abstract][Full Text] [Related]
3. Insulin-induced vasoconstriction is prevalent in muscle microvasculature of otherwise healthy persons with type 1 diabetes.
Jahn LA; Hartline LM; Kleiner AJ; Horton WB; Hasan F; Wai Kit Tan A; Liu Z; Barrett EJ
Am J Physiol Endocrinol Metab; 2023 May; 324(5):E402-E408. PubMed ID: 36920998
[TBL] [Abstract][Full Text] [Related]
4. Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia.
van de Ven KC; Tack CJ; Heerschap A; van der Graaf M; de Galan BE
J Clin Invest; 2013 Feb; 123(2):623-9. PubMed ID: 23298837
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort.
Millstein RJ; Pyle LL; Bergman BC; Eckel RH; Maahs DM; Rewers MJ; Schauer IE; Snell-Bergeon JK
J Diabetes Complications; 2018 Apr; 32(4):418-423. PubMed ID: 29449137
[TBL] [Abstract][Full Text] [Related]
6. Effect of epinephrine on glucose metabolism in humans: contribution of the liver.
Sherwin RS; Saccà L
Am J Physiol; 1984 Aug; 247(2 Pt 1):E157-65. PubMed ID: 6380304
[TBL] [Abstract][Full Text] [Related]
7. Protein fructosylation: fructose and the Maillard reaction.
Dills WL
Am J Clin Nutr; 1993 Nov; 58(5 Suppl):779S-787S. PubMed ID: 8213610
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.
She R; Suvitaival T; Andersen HU; Hommel E; Nørgaard K; Wojtaszewski JFP; Legido-Quigley C; Pedersen-Bjergaard U
Diabetologia; 2024 Jun; 67(6):1095-1106. PubMed ID: 38427076
[TBL] [Abstract][Full Text] [Related]
9. Decreased branched-chain amino acids and elevated fatty acids during antecedent hypoglycemia in type 1 diabetes.
She R; Al-Sari NH; Mattila IM; Sejling AS; Pedersen J; Legido-Quigley C; Pedersen-Bjergaard U
BMJ Open Diabetes Res Care; 2023 Jun; 11(3):. PubMed ID: 37369531
[TBL] [Abstract][Full Text] [Related]
10. The progression of secondary diabetes: A review of modeling studies.
Yang B; Li J; Haller MJ; Schatz DA; Rong L
Front Endocrinol (Lausanne); 2022; 13():1070979. PubMed ID: 36619543
[TBL] [Abstract][Full Text] [Related]
11. Sympathectomy Effects on Intra-Abdominal Organ Catecholamine Levels in a Streptozotocin-Induced Diabetic Rat Model.
Pérez-Juárez A; Aguirre-Pérez AG; Barrientos-Alvarado C
Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556512
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell free DNA response to exhaustive exercise in average trained men with type I diabetes mellitus.
Walczak K; Stawski R; Perdas E; Brzezinska O; Kosielski P; Galczynski S; Budlewski T; Padula G; Nowak D
Sci Rep; 2021 Feb; 11(1):4639. PubMed ID: 33633280
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine-Like Analogues in Diabetes: Speeding towards Ketogenesis.
Branis NM; Wittlin SD
Case Rep Endocrinol; 2015; 2015():917869. PubMed ID: 25960894
[TBL] [Abstract][Full Text] [Related]
14. Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes.
Briscoe VJ; Ertl AC; Tate DB; Davis SN
Diabetes; 2008 Dec; 57(12):3315-22. PubMed ID: 18835927
[TBL] [Abstract][Full Text] [Related]
15. Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals.
Briscoe VJ; Ertl AC; Tate DB; Dawling S; Davis SN
Diabetes; 2008 Sep; 57(9):2453-60. PubMed ID: 18567822
[TBL] [Abstract][Full Text] [Related]
16. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
[TBL] [Abstract][Full Text] [Related]
17. Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes.
Aftab Guy D; Sandoval D; Richardson MA; Tate D; Davis SN
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E258-65. PubMed ID: 15784645
[TBL] [Abstract][Full Text] [Related]
18. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes.
Galassetti P; Tate D; Neill RA; Morrey S; Wasserman DH; Davis SN
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E16-24. PubMed ID: 14998785
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
